Role of Inflammatory Mechanisms in Major Depressive Disorder: From Etiology to Potential Pharmacological Targets

The involvement of central and peripheral inflammation in the pathogenesis and prognosis of major depressive disorder (MDD) has been demonstrated. The increase of pro-inflammatory cytokines (interleukin (IL)-1β, IL-6, IL-18, and TNF-α) in individuals with depression may elicit neuroinflammatory proc...

Full description

Bibliographic Details
Main Authors: Bruna R. Kouba, Laura de Araujo Borba, Pedro Borges de Souza, Joana Gil-Mohapel, Ana Lúcia S. Rodrigues
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/13/5/423
_version_ 1797264700770091008
author Bruna R. Kouba
Laura de Araujo Borba
Pedro Borges de Souza
Joana Gil-Mohapel
Ana Lúcia S. Rodrigues
author_facet Bruna R. Kouba
Laura de Araujo Borba
Pedro Borges de Souza
Joana Gil-Mohapel
Ana Lúcia S. Rodrigues
author_sort Bruna R. Kouba
collection DOAJ
description The involvement of central and peripheral inflammation in the pathogenesis and prognosis of major depressive disorder (MDD) has been demonstrated. The increase of pro-inflammatory cytokines (interleukin (IL)-1β, IL-6, IL-18, and TNF-α) in individuals with depression may elicit neuroinflammatory processes and peripheral inflammation, mechanisms that, in turn, can contribute to gut microbiota dysbiosis. Together, neuroinflammation and gut dysbiosis induce alterations in tryptophan metabolism, culminating in decreased serotonin synthesis, impairments in neuroplasticity-related mechanisms, and glutamate-mediated excitotoxicity. This review aims to highlight the inflammatory mechanisms (neuroinflammation, peripheral inflammation, and gut dysbiosis) involved in the pathophysiology of MDD and to explore novel anti-inflammatory therapeutic approaches for this psychiatric disturbance. Several lines of evidence have indicated that in addition to antidepressants, physical exercise, probiotics, and nutraceuticals (agmatine, ascorbic acid, and vitamin D) possess anti-inflammatory effects that may contribute to their antidepressant properties. Further studies are necessary to explore the therapeutic benefits of these alternative therapies for MDD.
first_indexed 2024-04-25T00:33:04Z
format Article
id doaj.art-23a4019be57e4d0aac2f25ee9706e12e
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-04-25T00:33:04Z
publishDate 2024-02-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-23a4019be57e4d0aac2f25ee9706e12e2024-03-12T16:41:39ZengMDPI AGCells2073-44092024-02-0113542310.3390/cells13050423Role of Inflammatory Mechanisms in Major Depressive Disorder: From Etiology to Potential Pharmacological TargetsBruna R. Kouba0Laura de Araujo Borba1Pedro Borges de Souza2Joana Gil-Mohapel3Ana Lúcia S. Rodrigues4Department of Biochemistry, Center of Biological Sciences, Universidade Federal de Santa Catarina, Florianópolis 88040-900, SC, BrazilDepartment of Biochemistry, Center of Biological Sciences, Universidade Federal de Santa Catarina, Florianópolis 88040-900, SC, BrazilDepartment of Biochemistry, Center of Biological Sciences, Universidade Federal de Santa Catarina, Florianópolis 88040-900, SC, BrazilIsland Medical Program, Faculty of Medicine, University of British Columbia, Victoria, BC V8P 5C2, CanadaDepartment of Biochemistry, Center of Biological Sciences, Universidade Federal de Santa Catarina, Florianópolis 88040-900, SC, BrazilThe involvement of central and peripheral inflammation in the pathogenesis and prognosis of major depressive disorder (MDD) has been demonstrated. The increase of pro-inflammatory cytokines (interleukin (IL)-1β, IL-6, IL-18, and TNF-α) in individuals with depression may elicit neuroinflammatory processes and peripheral inflammation, mechanisms that, in turn, can contribute to gut microbiota dysbiosis. Together, neuroinflammation and gut dysbiosis induce alterations in tryptophan metabolism, culminating in decreased serotonin synthesis, impairments in neuroplasticity-related mechanisms, and glutamate-mediated excitotoxicity. This review aims to highlight the inflammatory mechanisms (neuroinflammation, peripheral inflammation, and gut dysbiosis) involved in the pathophysiology of MDD and to explore novel anti-inflammatory therapeutic approaches for this psychiatric disturbance. Several lines of evidence have indicated that in addition to antidepressants, physical exercise, probiotics, and nutraceuticals (agmatine, ascorbic acid, and vitamin D) possess anti-inflammatory effects that may contribute to their antidepressant properties. Further studies are necessary to explore the therapeutic benefits of these alternative therapies for MDD.https://www.mdpi.com/2073-4409/13/5/423anti-inflammatory approachesgut dysbiosisinflammationmajor depressive disorder
spellingShingle Bruna R. Kouba
Laura de Araujo Borba
Pedro Borges de Souza
Joana Gil-Mohapel
Ana Lúcia S. Rodrigues
Role of Inflammatory Mechanisms in Major Depressive Disorder: From Etiology to Potential Pharmacological Targets
Cells
anti-inflammatory approaches
gut dysbiosis
inflammation
major depressive disorder
title Role of Inflammatory Mechanisms in Major Depressive Disorder: From Etiology to Potential Pharmacological Targets
title_full Role of Inflammatory Mechanisms in Major Depressive Disorder: From Etiology to Potential Pharmacological Targets
title_fullStr Role of Inflammatory Mechanisms in Major Depressive Disorder: From Etiology to Potential Pharmacological Targets
title_full_unstemmed Role of Inflammatory Mechanisms in Major Depressive Disorder: From Etiology to Potential Pharmacological Targets
title_short Role of Inflammatory Mechanisms in Major Depressive Disorder: From Etiology to Potential Pharmacological Targets
title_sort role of inflammatory mechanisms in major depressive disorder from etiology to potential pharmacological targets
topic anti-inflammatory approaches
gut dysbiosis
inflammation
major depressive disorder
url https://www.mdpi.com/2073-4409/13/5/423
work_keys_str_mv AT brunarkouba roleofinflammatorymechanismsinmajordepressivedisorderfrometiologytopotentialpharmacologicaltargets
AT lauradearaujoborba roleofinflammatorymechanismsinmajordepressivedisorderfrometiologytopotentialpharmacologicaltargets
AT pedroborgesdesouza roleofinflammatorymechanismsinmajordepressivedisorderfrometiologytopotentialpharmacologicaltargets
AT joanagilmohapel roleofinflammatorymechanismsinmajordepressivedisorderfrometiologytopotentialpharmacologicaltargets
AT analuciasrodrigues roleofinflammatorymechanismsinmajordepressivedisorderfrometiologytopotentialpharmacologicaltargets